Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma

Publisher： Karger

E-ISSN： 1662-6575|6|2|441-449

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.6, Iss.2, 2013-08, pp. : 441-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastroenteropancreatic high‐grade neuroendocrine carcinoma

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2814-2823

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial Carcinoma

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-06 ,pp. : 493-500

Karger

Access to resources Recommend Favorite

Assessment of cytologic differentiation in high‐grade pancreatic neuroendocrine neoplasms: A multi‐institutional study

By  

CANCER CYTOPATHOLOGY, Vol. 126, Iss. 1, 2018-01 ,pp. : 44-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy

By  

Case Reports in Oncology, Vol. 4, Iss. 2, 2011-05 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

High‐grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high‐grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 806-816

John Wiley & Sons Inc

Access to resources Recommend Favorite